Amarin Corp Plc (AMRN)

[Chemist2]

Hi Raf; The principal findings confuse by using first volume(for LAP) in mm3 and then give other data a 5 change from baseline.
So we do not know what the % changes are for the LAP but are give the changes for the other types of plaque. So for "total" plaque we have an 11% increase from baseline in the placebo arm and a 9& DECREASE in the V arm.
So we have regression in total plaque but insufficent info to say if the LAP actually regressed. Presumably additional info in paper allows that answer to be found/determined!